Baar, 12 April 2023 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients (the “Company”), today announced that the shareholders approved all proposals put forward by the Board of Directors at the Company’s second annual General Meeting (“AGM 2023”) that took place at the Chollerhalle Zug with a large majority.
The Executive Chairman of the Board of Directors, Peter Wilden, welcomed the shareholders at the Chollerhalle Zug, where a total of 25,522,031 shares with voting rights were represented, corresponding to 77.05% of the issued registered shares of the Company.
All six members of the Board of Directors proposed for re-election and the proposed new independent member of the Board of Directors, Dorothee A. Deuring, were appointed for a term of office ending at the conclusion of the next annual General Meeting 2024. Peter Wilden was re-elected as Chairman of the Board of Directors, and Philippe Weber and Peter Wilden were each individually re-elected as members of the Remuneration and Nomination Committee for a term of office ending at the conclusion of the next annual General Meeting 2024.
Shareholders also approved the Board of Directors’ proposal for the amendments of the Articles of Association implementing, inter alia, the requirements of the revised Swiss corporate law that entered into force on 1 January 2023.
Further proposals of the Board of Directors that were approved at the AGM 2023 included, among others, the re-election of the Independent Proxy and the Statutory Auditors as well as the approval of the maximum aggregate amount of compensation of the Board of Directors and Executive Committee. The shareholders also granted discharge to all members of the Board of Directors and Executive Committee for their activities in the financial year 2022 and approved the Annual Report, Statutory Financial Statements and Consolidated Financial Statements, in each case, for the financial year 2022 as well as the Remuneration Report 2022 in a separate consultative vote.
The minutes of the AGM 2023 will be available within 15 days here. The next annual General Meeting 2024 will be held on 10 April 2024. […]
The necessary cookies help to make a website usable by enabling basic functions such as page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
Marketing cookies are used to track visitors through websites. The goal is to display ads that are relevant and interesting to the individual user and therefore more valuable to third-party publishers and advertisers.
Statistical cookies help website owners, through the anonymous collection and communication of information, to understand how visitors interact with websites.
Preferences cookies allow a website to retain information that changes the way the site behaves or displays, such as your preferred language or the region in which you are located.